{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:04Z","timestamp":1793382964966,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding under Grant","award":["2022-PUMCH-C-069"],"award-info":[{"award-number":["2022-PUMCH-C-069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09757-4","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:02:24Z","timestamp":1724842944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yujie","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"issue":"9","key":"9757_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515\u201332.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"9757_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/rheumatology\/keaa267","volume":"60","author":"IEM Bultink","year":"2021","unstructured":"Bultink IEM, de Vries F, van Vollenhoven RF, Lalmohamed A. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls. Rheumatology (Oxford). 2021;60(1):207\u201316.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"9757_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10067-018-4259-z","volume":"38","author":"XY Wu","year":"2019","unstructured":"Wu XY, Yang M, Xie YS, Xiao WG, Lin J, Zhou B, et al. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort. Clin Rheumatol. 2019;38(1):107\u201315.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"9757_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/annrheumdis-2018-214802","volume":"78","author":"K Tselios","year":"2019","unstructured":"Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971\u20132013). Ann Rheum Dis. 2019;78(6):802\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9757_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/acr.22173","volume":"66","author":"M Yurkovich","year":"2014","unstructured":"Yurkovich M, Vostretsova K, Chen W, Avi\u00f1a-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2014;66(4):608\u201316.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"9757_CR6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00296-023-05469-1","volume":"43","author":"M Arrucha-Cozaya","year":"2023","unstructured":"Arrucha-Cozaya M, Zamora-Z\u00fa\u00f1iga NC, Miranda-Hern\u00e1ndez D, Bustamante-Gonz\u00e1lez R, Mart\u00ednez-D\u00edaz G, Tovar-Rodr\u00edguez D, et al. In-hospital mortality and associated factors in patients with systemic lupus erythematosus: analysis over more than 11 years in a reference hospital center. Rheumatol Int. 2023;43(12):2221\u201331.","journal-title":"Rheumatol Int"},{"issue":"8","key":"9757_CR7","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s10067-018-4102-6","volume":"37","author":"CL Teh","year":"2018","unstructured":"Teh CL, Wan SA, Ling GR. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Clin Rheumatol. 2018;37(8):2081\u20136.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"9757_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3899\/jrheum.151523","volume":"43","author":"D Chen","year":"2016","unstructured":"Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, et al. Infection in Southern Chinese patients with systemic Lupus Erythematosus: Spectrum, Drug Resistance, outcomes, and risk factors. J Rheumatol. 2016;43(9):1650\u20136.","journal-title":"J Rheumatol"},{"issue":"8","key":"9757_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/acr.22575","volume":"67","author":"MG Tektonidou","year":"2015","unstructured":"Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of serious infections in adults with systemic lupus erythematosus: a National Population-based study, 1996\u20132011. Arthritis Care Res (Hoboken). 2015;67(8):1078\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"9757_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/s10165-005-0395-9","volume":"15","author":"T Sato","year":"2005","unstructured":"Sato T, Inokuma S, Maezawa R, Nakayama H, Hamasaki K, Miwa Y, et al. Clinical characteristics of pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol. 2005;15(3):191\u20137.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"9757_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018;22(1):307.","journal-title":"Crit Care"},{"issue":"2","key":"9757_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.mayocp.2020.07.029","volume":"96","author":"A Kanj","year":"2021","unstructured":"Kanj A, Samhouri B, Abdallah N, Chehab O, Baqir M. Host factors and outcomes in hospitalizations for Pneumocystis Jirovecii Pneumonia in the United States. Mayo Clin Proc. 2021;96(2):400\u20137.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"9757_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/RHU.0b013e31829d5017","volume":"19","author":"CT Weng","year":"2013","unstructured":"Weng CT, Liu MF, Weng MY, Lee NY, Wang MC, Lin WC, et al. Pneumocystis Jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan. J Clin Rheumatol. 2013;19(5):252\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"8","key":"9757_CR14","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic Lupus International collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677\u201386.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9757_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"9757_CR16","doi-asserted-by":"publisher","first-page":"e15997","DOI":"10.1097\/MD.0000000000015997","volume":"98","author":"ZG Wang","year":"2019","unstructured":"Wang ZG, Liu XM, Wang Q, Chen NF, Tong SQ. A retrospective study of patients with systemic lupus erythematosus combined with pneumocystis jiroveci pneumonia treated with caspofungin and trimethoprim\/sulfamethoxazole. Med (Baltim). 2019;98(23):e15997.","journal-title":"Med (Baltim)"},{"issue":"9","key":"9757_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/acr.24584","volume":"74","author":"WH Wang","year":"2022","unstructured":"Wang WH, Lai CC, Huang YF, Li TH, Tsao YP, Chen WS, et al. Pneumocystis Jirovecii Pneumonia in systemic lupus erythematosus: a Nationwide Cohort Study in Taiwan. Arthritis Care Res (Hoboken). 2022;74(9):1444\u201350.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"9757_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jinf.2014.02.015","volume":"69","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Lee J, Cho YJ, Park YS, Lee CH, Yoon HI, et al. Prognostic factors of Pneumocystis Jirovecii pneumonia in patients without HIV infection. J Infect. 2014;69(1):88\u201395.","journal-title":"J Infect"},{"issue":"1","key":"9757_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12879-016-1855-x","volume":"16","author":"L Weng","year":"2016","unstructured":"Weng L, Huang X, Chen L, Feng LQ, Jiang W, Hu XY, et al. Prognostic factors for severe pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study. BMC Infect Dis. 2016;16(1):528.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"9757_CR20","doi-asserted-by":"publisher","first-page":"e0139144","DOI":"10.1371\/journal.pone.0139144","volume":"10","author":"M Chen","year":"2015","unstructured":"Chen M, Tian X, Qin F, Zhou J, Liu J, Wang M, et al. Pneumocystis Pneumonia in patients with Autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death. PLoS ONE. 2015;10(9):e0139144.","journal-title":"PLoS ONE"},{"issue":"5","key":"9757_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.semarthrit.2020.06.004","volume":"50","author":"Q Yuan","year":"2020","unstructured":"Yuan Q, Xing X, Lu Z, Li X. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2020;50(5):1022\u201339.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"9757_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5009\/gnl230152","volume":"18","author":"J Yoon","year":"2024","unstructured":"Yoon J, Hong SW, Han KD, Lee SW, Shin CM, Park YS, et al. Risk factors of Pneumocystis Jirovecii Pneumonia in patients with inflammatory bowel disease: a Nationwide Population-based study. Gut Liver. 2024;18(3):489\u201397.","journal-title":"Gut Liver"},{"issue":"1","key":"9757_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.682","volume":"23","author":"AY Peleg","year":"2007","unstructured":"Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23(1):3\u201313.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"9757_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/JLB.5VMR0118-021RR","volume":"104","author":"LM Frydrych","year":"2018","unstructured":"Frydrych LM, Bian G, O\u2019Lone DE, Ward PA, Delano MJ. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525\u201334.","journal-title":"J Leukoc Biol"},{"key":"9757_CR25","doi-asserted-by":"publisher","first-page":"1131258","DOI":"10.3389\/fcimb.2023.1131258","volume":"13","author":"X Zhao","year":"2023","unstructured":"Zhao X, Duan MX, Lu YY, Bai LP, Zhao XY. Short-term prognostic analysis of patients with systemic lupus erythematosus co-infection and comparison of mNGS and conventional microbiological test results. Front Cell Infect Microbiol. 2023;13:1131258.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"9757_CR26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3899\/jrheum.131261","volume":"41","author":"A Barrera-Vargas","year":"2014","unstructured":"Barrera-Vargas A, G\u00f3mez-Mart\u00edn D, Merayo-Chalico J, Ponce-de-Le\u00f3n A, Alcocer-Varela J. Risk factors for drug-resistant bloodstream infections in patients with systemic lupus erythematosus. J Rheumatol. 2014;41(7):1311\u20136.","journal-title":"J Rheumatol"},{"issue":"3","key":"9757_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ajt.12055","volume":"13","author":"M Fern\u00e1ndez-Ruiz","year":"2013","unstructured":"Fern\u00e1ndez-Ruiz M, L\u00f3pez-Medrano F, Varela-Pe\u00f1a P, Morales JM, Garc\u00eda-Reyne A, San Juan R, et al. Hypocomplementemia in kidney transplant recipients: impact on the risk of infectious complications. Am J Transpl. 2013;13(3):685\u201394.","journal-title":"Am J Transpl"},{"issue":"6","key":"9757_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/1756-185X.13555","volume":"22","author":"Z Lu","year":"2019","unstructured":"Lu Z, Li J, Ji J, Da Z. Mortality prediction in systemic lupus erythematosus patients with pulmonary infection. Int J Rheum Dis. 2019;22(6):1077\u201383.","journal-title":"Int J Rheum Dis"},{"issue":"48","key":"9757_CR29","doi-asserted-by":"publisher","first-page":"16879","DOI":"10.1073\/pnas.0406678101","volume":"101","author":"EA Nordahl","year":"2004","unstructured":"Nordahl EA, Rydeng\u00e5rd V, Nyberg P, Nitsche DP, M\u00f6rgelin M, Malmsten M, et al. Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A. 2004;101(48):16879\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 8","key":"9757_CR30","doi-asserted-by":"publisher","first-page":"I3","DOI":"10.1016\/j.vaccine.2008.11.010","volume":"26","author":"F Tedesco","year":"2008","unstructured":"Tedesco F. Inherited complement deficiencies and bacterial infections. Vaccine. 2008;26(Suppl 8):I3\u20138.","journal-title":"Vaccine"},{"issue":"11","key":"9757_CR31","doi-asserted-by":"publisher","first-page":"e50327","DOI":"10.1371\/journal.pone.0050327","volume":"7","author":"J Bode","year":"2012","unstructured":"Bode J, Dutow P, Sommer K, Janik K, Glage S, T\u00fcmmler B, et al. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci. PLoS ONE. 2012;7(11):e50327.","journal-title":"PLoS ONE"},{"issue":"14","key":"9757_CR32","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ, Complement. First of two parts. N Engl J Med. 2001;344(14):1058\u201366.","journal-title":"N Engl J Med"},{"issue":"6","key":"9757_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00011-012-0448-4","volume":"61","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Ren J, Gu G, Cao S, Li J. The effect of human complement C3 protein applied at different times in treatment of polymicrobial sepsis. Inflamm Res. 2012;61(6):581\u20139.","journal-title":"Inflamm Res"},{"issue":"1","key":"9757_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12879-020-4826-1","volume":"20","author":"KJ Yeo","year":"2020","unstructured":"Yeo KJ, Chen HH, Chen YM, Lin CH, Chen DY, Lai CM, et al. Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study. BMC Infect Dis. 2020;20(1):112.","journal-title":"BMC Infect Dis"},{"key":"9757_CR35","doi-asserted-by":"publisher","first-page":"732681","DOI":"10.3389\/fmed.2021.732681","volume":"8","author":"Y Yang","year":"2021","unstructured":"Yang Y, Jiang H, Wang C, Jiang N, Wu C, Zhang S, et al. Clinical characteristics and prognoses of patients with systemic Lupus Erythematosus hospitalized for pulmonary infections. Front Med (Lausanne). 2021;8:732681.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"9757_CR36","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/infdis\/jit103","volume":"207","author":"SS Henriet","year":"2013","unstructured":"Henriet SS, Jans J, Simonetti E, Kwon-Chung KJ, Rijs AJ, Hermans PW, et al. Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease. J Infect Dis. 2013;207(12):1932\u20139.","journal-title":"J Infect Dis"},{"issue":"6","key":"9757_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/art.39070","volume":"67","author":"CH Feldman","year":"2015","unstructured":"Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, et al. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015;67(6):1577\u201385.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"9757_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/S0036-46652005000300005","volume":"47","author":"LS Azevedo","year":"2005","unstructured":"Azevedo LS, Castro MC, Paula FJ, Ianhez LE, David-Neto E. Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients. Rev Inst Med Trop Sao Paulo. 2005;47(3):143\u20135.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"4","key":"9757_CR39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1086\/513988","volume":"175","author":"HS Oz","year":"1997","unstructured":"Oz HS, Hughes WT. Novel anti-pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. J Infect Dis. 1997;175(4):901\u20134.","journal-title":"J Infect Dis"},{"issue":"3","key":"9757_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"JL JVincent","year":"2003","unstructured":"JVincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319\u201334.","journal-title":"Ann Surg"},{"issue":"1","key":"9757_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12890-019-0813-y","volume":"19","author":"S Kumagai","year":"2019","unstructured":"Kumagai S, Arita M, Koyama T, Kumazawa T, Inoue D, Nakagawa A, et al. Prognostic significance of crazy paving ground grass opacities in non-HIV pneumocystis jirovecii pneumonia: an observational cohort study. BMC Pulm Med. 2019;19(1):47.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"9757_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/imr.12030","volume":"252","author":"JK Kolls","year":"2013","unstructured":"Kolls JK. CD4(+) T-cell subsets and host defense in the lung. Immunol Rev. 2013;252(1):156\u201363.","journal-title":"Immunol Rev"},{"issue":"8","key":"9757_CR43","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3109\/13693786.2010.484027","volume":"48","author":"X Iriart","year":"2010","unstructured":"Iriart X, Witkowski B, Courtais C, Abbes S, Tkaczuk J, Courtade M, et al. Cellular and cytokine changes in the alveolar environment among immunocompromised patients during pneumocystis jirovecii infection. Med Mycol. 2010;48(8):1075\u201387.","journal-title":"Med Mycol"},{"key":"9757_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijid.2017.02.010","volume":"57","author":"Y Li","year":"2017","unstructured":"Li Y, Ghannoum M, Deng C, Gao Y, Zhu H, Yu X, et al. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping. Int J Infect Dis. 2017;57:108\u201315.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"9757_CR45","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77(5):644\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9757_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/RHU.0b013e31817a7e30","volume":"14","author":"D Gupta","year":"2008","unstructured":"Gupta D, Zachariah A, Roppelt H, Patel AM, Gruber BL. Prophylactic antibiotic usage for Pneumocystis Jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature. J Clin Rheumatol. 2008;14(5):267\u201372.","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"9757_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-017-0664-6","volume":"19","author":"RM Wolfe","year":"2017","unstructured":"Wolfe RM, Peacock JE Jr. Pneumocystis Pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented? Curr Rheumatol Rep. 2017;19(6):35.","journal-title":"Curr Rheumatol Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09757-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:02:29Z","timestamp":1724842949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09757-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9757"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09757-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital (K5596) in accordance with the Declaration of Helsinki. Written informed consent from each patient was waived because our study was conducted using anonymized health care data, which met the IRB\u2019s minimal risk waiver criteria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"874"}}